Literature DB >> 24812415

Usefulness of a thyroglobulin liquid chromatography-tandem mass spectrometry assay for evaluation of suspected heterophile interference.

Brian C Netzel1, Stefan K G Grebe2, Alicia Algeciras-Schimnich3.   

Abstract

Mesh：

Substances：

Year:  2014        PMID： 24812415     DOI： 10.1373/clinchem.2014.224816

Source DB:  PubMed          Journal:  Clin Chem        ISSN： 0009-9147            Impact factor:   8.327


× No keyword cloud information.
  7 in total

1.  Thyroglobulin (Tg) Testing Revisited: Tg Assays, TgAb Assays, and Correlation of Results With Clinical Outcomes.

Authors:  Brian C Netzel; Stefan K G Grebe; B Gisella Carranza Leon; M Regina Castro; Penelope M Clark; Andrew N Hoofnagle; Carole A Spencer; Adina F Turcu; Alicia Algeciras-Schimnich
Journal:  J Clin Endocrinol Metab       Date:  2015-06-16       Impact factor: 5.958

2.  Quantitation of Thyroglobulin in Serum Using SISCAPA and Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS).

Authors:  J Grace van der Gugten; Morty Razavi; Daniel T Holmes
Journal:  Methods Mol Biol       Date:  2022

Review 3.  Clinical potential of mass spectrometry-based proteogenomics.

Authors:  Bing Zhang; Jeffrey R Whiteaker; Andrew N Hoofnagle; Geoffrey S Baird; Karin D Rodland; Amanda G Paulovich
Journal:  Nat Rev Clin Oncol       Date:  2019-04       Impact factor: 66.675

4.  Calcitonin testing for detection of medullary thyroid cancer in people with thyroid nodules.

Authors:  Hans Hg Verbeek; Jan Willem B de Groot; Wim J Sluiter; Anneke C Muller Kobold; Edwin R van den Heuvel; John Tm Plukker; Thera P Links
Journal:  Cochrane Database Syst Rev       Date:  2020-03-16

5.  Serum thyroglobulin (Tg) monitoring of patients with differentiated thyroid cancer using sensitive (second-generation) immunometric assays can be disrupted by false-negative and false-positive serum thyroglobulin autoantibody misclassifications.

Authors:  Carole Spencer; Ivana Petrovic; Shireen Fatemi; Jonathan LoPresti
Journal:  J Clin Endocrinol Metab       Date:  2014-12       Impact factor: 5.958

Review 6.  The next horizon in precision oncology: Proteogenomics to inform cancer diagnosis and treatment.

Authors:  Henry Rodriguez; Jean Claude Zenklusen; Louis M Staudt; James H Doroshow; Douglas R Lowy
Journal:  Cell       Date:  2021-04-01       Impact factor: 41.582

7.  Falsely elevated thyroglobulin and calcitonin due to rheumatoid factor in non-relapsing thyroid carcinoma: A case report.

Authors:  Gelsy Arianna Lupoli; Livia Barba; Antonietta Liotti; Evelina La Civita; Roberta Lupoli; Enrico Riccio; Giuseppe Portella; Pietro Formisano; Francesco Beguinot; Daniela Terracciano
Journal:  Medicine (Baltimore)       Date:  2019-02       Impact factor: 1.817
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.